NJ ACTS Finds Universities Teaming Up to Transform NJ Health Care

Dec. 8, 2019

New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.

Organized by that consortium, the New Jersey Alliance for Clinical and Translational Science (NJACTS) – featuring thought leaders from academia, health care, government and the pharmaceutical industry – recently discussed the future of New Jersey scientific and clinical trial innovation resulting from a $33 million grant from the National Institutes of Health (NIH) at the Rutgers Livingston Student Center. Continue to read full article